Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome [1]

Annals of Oncology

Volumn 19, Issue 3, 2008, Pages 595-

  Dietrich, Pierre Yves ^a   Duchosal, M A ^b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; IMMUNOGLOBULIN A; MELPHALAN; PARAPROTEIN; VASCULOTROPIN;

ADULT; AUTOLOGOUS STEM CELL TRANSPLANTATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DYSPHAGIA; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; ENDOCRINE DISEASE; FEMALE; HUMAN; LETTER; LUNG FUNCTION TEST; MONOCLONAL IMMUNOGLOBULINEMIA; NERVE CONDUCTION; NEUROPATHY; PARAPROTEINEMIA; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RESPIRATORY DISTRESS; SKIN DEFECT; STEROID THERAPY; VISCEROMEGALY; WALKING DIFFICULTY;

ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MIDDLE AGED; POEMS SYNDROME; PREMEDICATION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 40149099875     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm602     Document Type: Letter

References (5)

1. Dispenzieri A, Kyle RA, Lacy MQ et al. POEMS syndrome: Definitions and long-term outcome. Blood 2003; 101: 2496-2506.
2. Scarlato M, Previtali SC, Carpo M et al. Polyneuropathy in POEMS syndrome: Role of angiogenic factors in the pathogenesis. Brain 2005; 128: 1911-1920.
3. Dispenzieri A, Moreno-Aspitia A, Suarez GA et al. Peripheral blood stem transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004; 104: 3400-3407.
4. Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood 2005; 106: 1135.
5. Straume O, Bergheim J, Ernst P. Bevacizumab therapy for POEMS syndrome. Blood 2006; 107: 4972-4973.